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Stephanie, a good friend of mine, experienced her #rst mi-
graine on her twel%h birthday. From then on, she had mi-
graines at least once a month, sometimes with additional 
symptoms such as a partial loss of vision, as well as nausea 
and numbness. In high school, she was an active girl and an 
ace on the tennis court. I remember that her headaches were 
sometimes so debilitating that she missed class and fainted 
once during a varsity game. Her mother, May, o%en consult-
ed her family doctors about her migraines. However, despite 
her more concerning episodes, the doctors never suspected 
an underlying cause. 
Looking back, May tells me she wishes she had listened to 
her motherly instincts and had urged more adamantly for 
a brain scan, which the doctors deemed unnecessary given 
that Stephanie only had a few other symptoms and that she 
had recovered from her spells a%er just a few hours of sleep. 
Stephanie remembers being reassured that migraines like 
hers were not too uncommon for teenage girls.
In September of her senior year of college, Stephanie went on 
vacation to Las Vegas. I had kept in touch with her since high 
school, but it had been a month since we last talked. I did not 
know that it would be another month before I heard from her 
again. A week prior to her vacation, she had experienced an 
unusual episode in which she had awoken unable to move 
her neck. Concerned, May had taken her to the doctor, but 
no conclusions were made that day. Stephanie later found out 
that she had su&ered a transient ischemic attack (TIA), fre-
quently referred to as a “mini-stroke”. On her last day in Las 
Vegas, Stephanie began to feel an oncoming migraine, which 
was exacerbated by the smoke-#lled lobby of her hotel. She 
collapsed and was taken to the hospital in a dire condition.
At the hospital, it was determined that she had su&ered a hem-
orrhagic stroke, and her parents were noti#ed immediately. 
!ey were given an extremely grave prognosis and asked to 
make a choice between two equally unbearable ends: the #rst 
was to let their daughter die peacefully; the second was to 
drill a hole into her skull and induce a coma. !ey declined 
medical intervention and prayed by Stephanie’s bedside. As 
May recalls, her daughter’s brain was swollen and under great 
pressure inside the skull; it wouldn’t be long before she was 
brain-dead. However, when the doctor arrived for his #nal 
round, he noticed signs that prompted a reevaluation of her 
mental status. It seemed like a miracle—Stephanie’s body re-
fused to succumb to death.
At this point, the necessary brain scans and angiogram were 
ordered, and the evidence viewed. Speculations about Steph-
anie’s condition began to surface in the minds of those treat-
ing her. Moyamoya disease (MMD) is a rare and relatively 
unknown disorder. Her doctors had heard of it but had never 
seen it, nor were they sure she even had it. In fact, I doubt 
I will ever come across this disease in my studies as a med-
ical student. Moyamoya is characterized by the progressive 
occlusion of both internal carotid arteries due to excessive 
growth of smooth muscle cells and luminal blood clot forma-
tion.1,2 As a compensatory reaction to the lack of blood $ow to 
the brain, numerous tiny and tortuous collateral arteries are 
formed. !ese are o%en thin, dilated, and subjected to high 
$ow stress, increasing the risk of microaneurysms.1,2 Patients 
o%en present with cerebrovascular problems such as TIAs, 
ischemic stroke, intracranial hemorrhage, migraines, or sei-
zures.
!e disease was #rst described in Japan, and its appearance 
on diagnostic angiograms was likened to a “pu& of smoke,” 
or “moyamoya”, in Japanese.2 !is telling arrangement of tiny 
blood vessels was revealed in Stephanie’s angiogram. 
An analysis of patients in the western United States revealed 
an overall prevalence of 0.086 per 100,000.1 However, a four-
fold greater incidence was found in Asian-Americans than in 
Caucasian Americans, supporting the possibility of a genetic 
etiology. Stephanie, who is Chinese-American, #ts this high-
er-risk pro#le. It has also been observed that the incidence of 
this disease is almost two times higher in females as in males. 
Furthermore, the incidence of the disease peaks in children 
around the age of 5, as well as in adults in their mid-40s.1,2
As is the case with many rare diseases, proper diagnosis is 
o%en hindered by many factors. Because Moyamoya is rela-
tively unknown, it is o%en misdiagnosed as multiple sclerosis 
or simply as migraines, as in Stephanie’s case.3 A delay in di-
agnosis can mean a delay in proper treatment and ultimately 
a higher risk of life-changing implications from stroke. !e 
situation is made worse when doctors attempt to treat the 
symptoms rather than work toward unveiling the underlying 
cause.
!ere is no cure for Moyamoya, but current treatments are 
successful in reducing the risk of future strokes by surgical 
revascularization of the cerebral hemispheres.1 Stephanie was 
lucky to be treated at Stanford University Medical Center, one 
of the few places in the country that specializes in Moyamoya.
!e #rst time I talked to Stephanie a%er her Las Vegas inci-
dent was during her recovery from surgery. I spoke to her as 
I would have on any other day, listening as she stumbled on 
words and repeated thoughts that she had voiced just minutes 
before.
May once told me her greatest fear was that when her daugh-
ter came back, she would not be the same Stephanie. It was 
a strangely emotional experience for me, knowing that she 
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would most likely live free of risk a%er surgery, yet wondering 
if her mother’s fears could somehow prevail.
Today, the most di"cult challenges of Moyamoya seem to 
be behind her. Stephanie has had no cognitive or motor im-
pairments as a result of the stroke and brain surgery. She has 
bounced back magni#cently. From my conversations with 
Stephanie and her family, I feel that the events of the past 
year have laid upon them a new lens through which they view 
their existence. Having experienced the darkest and bright-
est moments of death and of life, they now live with a secret 
spirituality that I do not know but can only presume. And 
there is nothing more that I can be or feel, than thankful for 
Stephanie’s full recovery—personality and all.
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